Search details
1.
Localized Changes in Dentate Nucleus Shape and Magnetic Susceptibility in Friedreich Ataxia.
Mov Disord
; 2024 Apr 22.
Article
in English
| MEDLINE | ID: mdl-38644761
2.
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes.
Cerebellum
; 23(2): 688-701, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-36997834
3.
A Review of Brain and Pituitary Gland MRI Findings in Patients with Ataxia and Hypogonadism.
Cerebellum
; 23(2): 757-774, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-37155088
4.
CHARON: An Imaging-Based Diagnostic Algorithm to Navigate Through the Sea of Hereditary Degenerative Ataxias.
Cerebellum
; 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38436911
5.
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis.
Eur J Neurol
; : e16280, 2024 Mar 24.
Article
in English
| MEDLINE | ID: mdl-38523419
6.
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy.
Eur J Neurol
; 31(6): e16180, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38117543
7.
Integration of the expanded disability status scale with ambulation, visual and cognitive tests.
Neurol Sci
; 2024 Apr 30.
Article
in English
| MEDLINE | ID: mdl-38689096
8.
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients.
Cerebellum
; 22(5): 1034-1038, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-36066808
9.
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study.
Cephalalgia
; 43(4): 3331024231161809, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36946234
10.
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta-analysis and network meta-analysis.
Eur J Neurol
; 30(12): 3854-3867, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37204031
11.
A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine.
Headache
; 63(6): 788-794, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37254581
12.
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective.
Neurol Sci
; 44(1): 45-58, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36114980
13.
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group.
Ann Neurol
; 90(4): 570-583, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34435700
14.
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.
Mult Scler
; 28(1): 93-101, 2022 01.
Article
in English
| MEDLINE | ID: mdl-33855897
15.
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.
Mult Scler
; 28(10): 1576-1590, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35229668
16.
A real-world study of alemtuzumab in a cohort of Italian patients.
Eur J Neurol
; 29(1): 257-266, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34558755
17.
Cognitive trajectories in multiple sclerosis: a long-term follow-up study.
Neurol Sci
; 43(2): 1215-1222, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34105018
18.
Othello syndrome in Parkinson's disease: a systematic review and report of a case series.
Neurol Sci
; 42(7): 2721-2729, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33978871
19.
The "crab sign": an imaging feature of spinocerebellar ataxia type 48.
Neuroradiology
; 62(9): 1095-1103, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32285148
20.
The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series.
Neurol Sci
; 41(3): 695-698, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31776867